Opinion: STAT+: How machine learning and automation can solve biomanufacturing scale-up challenges
Biomanufacturing has produced important materials, ingredients, therapeutics, and more for decades, yet it is still far from a mature industry. Given life’s 3.5 billion years of experimentation on Earth, it takes a lot of effort and resources to fully unleash nature’s potential for societal gain.
That said, biomanufacturing is entering a new age, spurred by the growth of synthetic biology and renewed investment in bioprocess innovations and technologies. Many have referred to this biomanufacturing renaissance as the next industrial revolution — a biorevolution.
